Á¦18ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°Á : 2020-09-12±³À°ÀÏÀÚ : 2020-09-12
±³À°Àå¼Ò : ¼ö¿ø ÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ :
Á¦18ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : ¼ö·ÃÀ§¿øȸ
¿¬¶ôó : 02-2038-0071
À̸ÞÀÏ :
endo@endocrinology.or.kr ±³À°Á¾·ù : ³»°úÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
°æ±âµµ ±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í Æò»ýȸ¿ø : 10¸¸¿ø Á¤È¸¿ø : 20¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-12 ±×·£µåº¼·ë 16:10~16:40 Phosphate metabolism and disorders ÀÌÀ¯¹Ì(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-12 ±×·£µåº¼·ë 16:40~17:10 Hypocalcemia and Hypoparathyroidism ±è¹üÁØ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-12 ±×·£µåº¼·ë 17:10~17:40 The Update of Romosozumab Á¤È£¿¬(°æÈñÀÇ´ë)
±³À°½Ã°£ 09-12 ±×·£µåº¼·ë 17:40~18:10 Medical Treatment for pituitary adenoma ±èÁ¤Èñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-12 ±×·£µåº¼·ë 18:10~18:40 Post-operation management of pituitary disease ±¸Ã¶·æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-12 ±×·£µåº¼·ë 18:40~19:10 Long term treatment of hypopituitarism ÀÓµ¿ÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-12 ±×·£µåº¼·ë 19:10~19:30 ³»ºÐºñ´ë»ç³»°ú ºÐ°ú½ÃÇè ´ëºñ ±è¼ö°æ(Â÷ÀÇ°úÇдë)